1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Westlake Corporation agreed to sell $600 million of 5.550% senior notes due 2035 and $600 million of 6.375% senior notes due 2055, with closing expected November 6, 2025. The company expects net proceeds of about $1.185 billion, which it plans to use mainly to repurchase its $750 million of 3.600% senior notes due 2026, with any remainder going to the pending ACI Acquisition and general corporate purposes.
Two tranches total $1.2 billion: $600 million of 5.550% notes due November 15, 2035 and $600 million of 6.375% notes due November 15, 2055
Expected net proceeds of approximately $1.185 billion before offering expenses
Proceeds intended first to fund a concurrent tender offer for the $750 million of 3.600% senior notes due 2026 outstanding as of September 30, 2025
Remaining proceeds may fund the pending ACI/Perplastic Group compounding solutions acquisition and general corporate purposes
Halozyme proposed offering $650 million of convertible senior notes due 2031 and $650 million due 2032, with an option for up to $100 million more of each. The company also amended its credit agreement, extending the revolving facility to November 5, 2030 and raising total commitments to $750 million, with $0 currently drawn. The proceeds are partly earmarked for repurchasing existing 2027 and 2028 convertible notes, which adds debt while refinancing part of the existing convertible debt.
Proposed offering: $650 million of 2031 notes and $650 million of 2032 notes, plus a 13-day option for up to $100 million more of each series
Revolving credit facility commitments increased to $750 million and maturity extended to November 5, 2030, with no outstanding borrowings as of November 5, 2025
Net proceeds partly used for capped call transactions and privately negotiated repurchases of 0.25% notes due 2027 and 1.00% notes due 2028
Offering is subject to market conditions and pricing terms were not yet set in the filing
Kaiser Aluminum Corporation issued $500 million of 5.875% senior notes maturing March 1, 2034, under an indenture dated November 5, 2025. The company said it plans to use the proceeds, together with revolving credit facility borrowings and/or cash on hand, to redeem all outstanding 4.625% senior notes due 2028, which would refinance that debt with new borrowing.
$500.0 million aggregate principal of 5.875% senior notes due March 1, 2034, closed November 5, 2025
Interest is payable semiannually on March 1 and September 1, with the first payment on March 1, 2026
Proceeds, plus revolver borrowings and/or cash on hand, are planned to redeem all existing 4.625% senior notes due 2028
Notes were sold to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S; the company may redeem them on or after March 1, 2029
Tenet Healthcare entered a $1.9 billion senior secured revolving credit facility dated November 4, 2025, with JPMorgan Chase Bank as administrative agent, secured by first-priority liens on certain receivables and inventory. The company also extended its $200 million letter of credit facility to November 4, 2030. The filing describes a new borrowing arrangement and debt maturity extension rather than a change in reported results.
Revolving credit facility of up to $1.9 billion, with a $200 million sub-facility for letters of credit, maturing November 4, 2030, subject to springing maturity provisions
Facility is secured by first-priority liens on accounts receivable and inventory of Tenet and certain subsidiary guarantors
Letter of credit facility with Barclays Bank PLC extended from March 16, 2027 to November 4, 2030
Insight Digital Partners II, a blank check company with no operations, completed its initial public offering on October 30, 2025, selling 17,250,000 units at $10.00 each for $172.5 million in gross proceeds. The full $172.5 million was placed in a U.S.-based trust account, and the company must complete a business combination within 24 months of the offering closing or return the trust funds to public shareholders.
17,250,000 units sold at $10.00 each on October 30, 2025, including 2,250,000 units from the underwriters' full over-allotment option.
$172.5 million placed in a trust account maintained by Continental Stock Transfer & Trust Company.
Private placement of 5,450,000 warrants at $1.00 each, for $5.45 million in gross proceeds, sold to the Sponsor and the underwriters' representative.
The company has until 24 months from the offering closing to complete a business combination; it had not commenced any operations as of October 30, 2025.
Sherwin-Williams amended its credit agreement with Citicorp USA, Inc. as administrative agent, extending the maturity of $125,000,000 of borrowing and letter of credit commitments from December 20, 2025 to December 20, 2030. The filing describes the change as a routine extension of existing credit capacity, with no change in the amount of commitments stated.
Maturity of $125,000,000 of commitments extended from December 20, 2025 to December 20, 2030
Amendment No. 21 to the Credit Agreement dated May 9, 2016 signed November 5, 2025
Citicorp USA, Inc. serves as administrative agent and issuing bank
HNI Corporation entered into Amendment No. 1 to its Credit Agreement on November 5, 2025, with Wells Fargo Bank, National Association, as administrative agent, approved by all lenders under the existing agreement. The amendment sets a $105 million threshold for customary springing maturity dates on its revolving facility, term loan A facility and term loan B facility, and the filing describes it as a new direct financial obligation. The filing does not state any change in borrowing amounts or pricing, so the effect on shareholders is limited to the revised debt terms.
Amendment dated November 5, 2025, to the existing Credit Agreement with Wells Fargo Bank, National Association, as administrative agent
Amendment includes a $105 million threshold for springing maturity dates on the revolving facility, term loan A and term loan B facility
Approved by all lenders party to the Existing Credit Agreement; full text filed as Exhibit 10.1
Commercial Metals signed a Limited Consent and Second Amendment to its Credit Agreement on October 31, 2025, which permits a proposed $1.85 billion 364-day bridge facility and changes how certain monetary judgments are treated under the agreement's default provisions. The company also amended its October 15, 2025 commitment letter to remove a $600.0 million backstop facility, and the filing does not state the reason for these changes.
Second Amendment dated October 31, 2025 permits the bridge facility and waives conflicting credit agreement terms
Bridge Facility is a 364-day senior unsecured facility of up to $1.85 billion, per the October 15, 2025 commitment letter
$600.0 million backstop facility was eliminated from the commitment letter on October 31, 2025
Certain monetary judgments will no longer constitute an event of default; the $600.0 million revolving credit facility otherwise remains under the agreement
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.